BridgeBio Pharma, Inc. (BBIO) Balance Sheet
BBIO balance sheet, 2025
December 31, 2025 · U.S. dollars$936.0M assets = $3.01B liabilities + −$2.08B equity
Liabilities exceed assets: shareholders’ equity is negative (−$2.08B).
Both columns are drawn to the same scale: what BBIO owns equals what it owes plus shareholders’ equity. Hover a block for its value.
BBIO financial health
Descriptive bands, not a rating. Fiscal 2025.
BBIO balance sheet trends, 2017–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $98.0M2017 | $936.0M2025 | +32.6%/yr | |
| Total liabilities | $152.7M2017 | $3.01B2025 | +45.2%/yr | |
| Shareholders’ equity | −$58.0M2017 | −$2.08B2025 | — | |
| Cash & short-term investments | $92.0M2017 | $587.5M2025 | +26.1%/yr | |
| Total debt | $143.9M2017 | $2.73B2025 | +44.5%/yr | |
| Net cash (debt) | −$51.9M2017 | −$2.14B2025 | −$2.1B | |
| Working capital | $88.6M2017 | $465.7M2025 | +$377.1M | |
| Book value per share | −$0.632017 | −$10.532025 | — | |
| Current ratio | 11.362017 | 2.622025 | −8.74 | |
| Debt / equity | 0.222019 | 8.562020 | +8.34 | |
| Shares outstanding | 92.3M2017 | 197.2M2025 | +10.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
BBIO assets
BBIO liabilities and equity
BBIO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
BBIO balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & short-term investments | $587.5M | $681.1M | $434.9M | $471.9M | $836.7M | $607.1M | $546.0M | $436.1M | $92.0M |
| Cash & equivalents | $570.1M | $681.1M | $375.9M | $376.7M | $393.8M | $356.1M | $363.8M | $436.1M | $92.0M |
| Short-term investments | $17.4M | $0 | $58.9M | $95.2M | $442.9M | $251.0M | $182.2M | — | — |
| Receivables | $139.4M | $4.7M | $1.8M | $17.1M | $19.7M | $0 | $2.8M | $0 | $0 |
| Inventory | $26.8M | $0 | $16.7M | $37.9M | −$68.9M | $0 | $0 | $0 | $0 |
| Other current assets | $0 | $34.9M | $24.3M | $21.9M | $101.3M | $35.7M | $19.8M | $9.1M | $5.1M |
| Total current assets | $753.7M | $720.7M | $477.6M | $548.9M | $888.9M | $642.8M | $568.6M | $445.2M | $97.1M |
| Property, plant & equipment (net) | $13.5M | $12.8M | $19.8M | $25.2M | $46.0M | $36.8M | $5.6M | $1.6M | $440,000 |
| Goodwill & intangible assets | $28.1M | $23.9M | $26.3M | $28.7M | $44.9M | $0 | $0 | $0 | $0 |
| Long-term investments | $80.0M | $143.7M | $0 | $43.7M | $49.1M | $0 | $31.1M | $17.1M | $0 |
| Other non-current assets | $60.8M | $18.2M | $22.6M | $0 | $0 | $23.9M | $26.3M | $1.1M | $473,000 |
| Total assets | $936.0M | $919.3M | $546.4M | $623.0M | $1.01B | $703.6M | $631.7M | $464.9M | $98.0M |
| Liabilities | |||||||||
| Accounts payable | $36.2M | $9.6M | $10.7M | $11.6M | $11.9M | $8.9M | $8.9M | $13.5M | $1.9M |
| Short-term debt | $17.4M | $4.5M | $4.1M | $3.7M | $4.9M | $5.3M | $8.0M | — | — |
| Deferred revenue | $20.3M | $14.6M | $6.1M | $8.2M | — | $75.9M | $31.5M | — | — |
| Total current liabilities | $288.0M | $154.4M | $143.8M | $121.4M | $135.1M | $95.6M | $60.4M | $32.6M | $8.6M |
| Long-term debt | $1.85B | $1.72B | $1.73B | $1.71B | $1.70B | $475.9M | $91.8M | $54.5M | $0 |
| Lease obligations | $10.0M | $9.2M | $13.1M | $15.9M | $22.4M | $18.5M | $8.0M | — | — |
| Other long-term liabilities | $872.2M | $501.2M | $18.3M | $38.9M | $39.5M | $24.2M | $3.5M | $479.4M | $144.2M |
| Total liabilities | $3.01B | $2.38B | $1.89B | $1.87B | $1.88B | $595.7M | $155.7M | $566.4M | $152.7M |
| Shareholders' equity | |||||||||
| Common stock & paid-in capital | $202,000 | $196,000 | $181,000 | $157,000 | $154,000 | $125,000 | $124,000 | $6.6M | $3.4M |
| Retained earnings (deficit) | −$3.82B | −$3.10B | −$2.56B | −$1.92B | −$1.44B | −$888.8M | −$440.0M | −$170.6M | −$61.4M |
| Treasury stock | — | — | — | −$275.0M | −$275.0M | −$75.0M | — | — | — |
| Accumulated other comprehensive income | $12,000 | $7,999 | $31,000 | −$328,000 | −$132,000 | $191,999 | $254,000 | −$231,000 | −$27,000 |
| Minority interest | $10.0M | $10.3M | $11.7M | $11.3M | $3.4M | $48.4M | — | — | — |
| Total shareholders' equity | −$2.08B | −$1.47B | −$1.35B | −$1.25B | −$870.4M | $57.9M | $408.5M | −$164.0M | −$58.0M |
| Key figures | |||||||||
| Total debt | $2.73B | $1.73B | $1.74B | $1.72B | $1.73B | $495.8M | $91.8M | $54.5M | $143.9M |
| Net cash (debt) | −$2.14B | −$1.05B | −$1.30B | −$1.25B | −$889.5M | $111.3M | $454.2M | $381.6M | −$51.9M |
| Working capital | $465.7M | $566.3M | $333.7M | $427.4M | $753.8M | $547.2M | $508.2M | $412.6M | $88.6M |
| Tangible book value | −$2.10B | −$1.49B | −$1.38B | −$1.28B | −$915.3M | $57.9M | $408.5M | −$164.0M | −$58.0M |
| Book value per share | −$10.53 | −$7.89 | −$8.32 | −$8.51 | −$6.03 | $0.49 | $3.89 | −$1.78 | −$0.63 |
| Shares outstanding | 197.2M | 186.1M | 162.8M | 147.5M | 144.4M | 118.0M | 105.1M | 92.3M | 92.3M |
| Current ratio | 2.62 | 4.67 | 3.32 | 4.52 | 6.58 | 6.72 | 9.42 | 13.67 | 11.36 |
| Quick ratio | 2.52 | 4.44 | 3.04 | 4.03 | 6.34 | 6.35 | 9.09 | 13.39 | 10.76 |
| Debt / equity | — | — | — | — | — | 8.56 | 0.22 | — | — |
| Equity / assets | −221.9% | −159.7% | −247.9% | −201.4% | −85.9% | 8.2% | 64.7% | −35.3% | −59.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $720.2M | $940.2M | $587.5M | $645.9M | $757.3M | $540.6M | $681.1M | $266.3M | $587.2M | $519.8M | $434.9M | $543.3M |
| Cash & equivalents | $677.9M | $879.9M | $570.1M | $643.0M | $749.4M | $540.6M | $681.1M | $266.3M | $547.4M | $475.4M | $375.9M | $505.2M |
| Short-term investments | $42.2M | $60.3M | $17.4M | $3.0M | $7.9M | — | $0 | $0 | $39.8M | $44.5M | $58.9M | $38.1M |
| Receivables | $254.5M | $205.2M | $139.4M | $116.5M | $76.9M | $115.3M | $4.7M | $478,000 | $660,000 | $235.5M | $1.8M | $5.2M |
| Inventory | $52.8M | $33.0M | $26.8M | $24.5M | $18.3M | $4.0M | $0 | $0 | −$28.4M | $0 | $16.7M | $16.7M |
| Other current assets | $65.7M | $0 | $0 | $52.4M | $59.8M | $35.4M | $34.9M | $177.8M | $56.8M | $28.1M | $24.3M | $22.6M |
| Total current assets | $1.09B | $1.18B | $753.7M | $839.4M | $912.3M | $695.2M | $720.7M | $444.6M | $616.2M | $783.4M | $477.6M | $587.7M |
| Property, plant & equipment (net) | $22.3M | $22.2M | $13.5M | $12.4M | $12.3M | $13.9M | $12.8M | $15.1M | $17.1M | $19.5M | $19.8M | $21.7M |
| Goodwill & intangible assets | $26.6M | $27.4M | $28.1M | $28.8M | $29.5M | $27.8M | $23.9M | $24.5M | $25.1M | $25.7M | $26.3M | $26.9M |
| Long-term investments | $55.1M | $61.5M | $80.0M | $92.2M | $108.0M | $128.2M | $143.7M | $160.4M | $117.0M | $0 | $0 | $38.1M |
| Other non-current assets | $20.1M | $81.5M | $60.8M | $25.5M | $18.1M | $16.6M | $18.2M | $20.3M | $18.9M | $20.7M | $22.6M | $0 |
| Total assets | $1.22B | $1.37B | $936.0M | $998.2M | $1.08B | $881.6M | $919.3M | $665.0M | $794.4M | $849.3M | $546.4M | $655.0M |
| Liabilities | ||||||||||||
| Accounts payable | $27.2M | $29.1M | $36.2M | $18.7M | $26.1M | $27.5M | $9.6M | $13.4M | $18.1M | $4.7M | $10.7M | $4.5M |
| Short-term debt | $551.3M | $573.4M | $17.4M | $5.3M | $14.4M | $5.2M | $4.5M | $4.6M | $4.6M | $4.5M | $4.1M | $4.1M |
| Deferred revenue | $5.5M | $17.9M | $20.3M | $9.1M | $10.5M | $11.6M | $14.6M | $11.8M | $15.1M | $14.0M | $6.1M | $6.6M |
| Total current liabilities | $890.6M | $816.4M | $288.0M | $216.6M | $175.9M | $152.1M | $154.4M | $139.2M | $134.4M | $141.5M | $143.8M | $106.1M |
| Long-term debt | $1.93B | $1.93B | $1.85B | $1.85B | $1.85B | $1.85B | $1.72B | $1.72B | $1.72B | $1.72B | $1.73B | $1.72B |
| Lease obligations | $18.3M | $18.7M | $10.0M | $8.7M | $8.8M | $10.1M | $9.2M | $10.4M | $11.7M | $12.8M | $13.1M | $13.9M |
| Other long-term liabilities | $905.0M | $897.4M | $872.2M | $853.4M | $833.2M | $520.1M | $501.2M | $24.8M | $24.5M | $28.8M | $18.3M | $21.6M |
| Total liabilities | $3.72B | $3.64B | $3.01B | $2.92B | $2.86B | $2.52B | $2.38B | $1.88B | $1.88B | $1.89B | $1.89B | $1.85B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $206,000 | $204,000 | $202,000 | $200,000 | $198,000 | $197,000 | $196,000 | $195,000 | $194,000 | $193,000 | $181,000 | $180,000 |
| Retained earnings (deficit) | −$4.14B | −$3.99B | −$3.82B | −$3.63B | −$3.45B | −$3.26B | −$3.10B | −$2.83B | −$2.67B | −$2.60B | −$2.56B | −$2.39B |
| Accumulated other comprehensive income | −$7,000 | −$8,000 | $12,000 | $2,000 | $1,000 | $0 | $7,999 | $5,000 | −$4,000 | $2,000 | $31,000 | $34,000 |
| Minority interest | $9.3M | $9.5M | $10.0M | $10.3M | $9.4M | — | — | — | — | — | — | — |
| Total shareholders' equity | −$2.52B | −$2.27B | −$2.08B | −$1.93B | −$1.79B | −$1.65B | −$1.47B | −$1.23B | −$1.09B | −$1.05B | −$1.35B | −$1.21B |
| Key figures | ||||||||||||
| Total debt | $2.49B | $3.38B | $2.73B | $1.86B | $2.68B | $1.86B | $1.73B | $1.73B | $1.73B | $1.73B | $1.74B | $1.74B |
| Net cash (debt) | −$1.77B | −$2.44B | −$2.14B | −$1.21B | −$1.92B | −$1.32B | −$1.05B | −$1.46B | −$1.14B | −$1.21B | −$1.30B | −$1.19B |
| Working capital | $202.5M | $362.0M | $465.7M | $622.8M | $736.4M | $543.1M | $566.3M | $305.4M | $481.9M | $641.9M | $333.7M | $481.6M |
| Tangible book value | −$2.54B | −$2.30B | −$2.10B | −$1.96B | −$1.82B | −$1.68B | −$1.49B | −$1.25B | −$1.12B | −$1.08B | −$1.38B | −$1.23B |
| Book value per share | −$12.85 | −$11.65 | −$10.53 | −$10.15 | −$9.38 | −$8.67 | −$7.75 | −$6.52 | −$5.83 | −$5.87 | −$7.76 | −$7.39 |
| Shares outstanding | 195.8M | 194.8M | 197.2M | 190.5M | 190.5M | 190.1M | 189.4M | 188.5M | 187.6M | 178.7M | 174.5M | 163.3M |
| Current ratio | 1.23 | 1.44 | 2.62 | 3.88 | 5.19 | 4.57 | 4.67 | 3.19 | 4.59 | 5.54 | 3.32 | 5.54 |
| Quick ratio | 1.09 | 1.40 | 2.52 | 3.52 | 4.74 | 4.31 | 4.44 | 1.92 | 4.37 | 5.34 | 3.04 | 5.17 |
| Equity / assets | −206.6% | −165.5% | −221.9% | −193.6% | −165.5% | −187.0% | −159.7% | −185.0% | −137.6% | −123.6% | −247.9% | −184.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 24, 2026); data from EODHD.
BBIO financial position
At the end of fiscal 2025 (December 31, 2025), BridgeBio Pharma had total assets of $936.0 million (up 1.8% from a year earlier), total liabilities of $3.0 billion and shareholders' equity of -$2.1 billion. It held $587.5 million in cash and short-term investments against $2.7 billion of debt, net debt of $2.1 billion. Its current ratio was 2.62. In the latest quarter (ended June 30, 2026) total assets were $1.2 billion and equity -$2.5 billion.
Related: BBIO income statement, BBIO cash flow statement, BBIO key metrics. See the BBIO stock overview for the latest quote and news.
BBIO balance sheet FAQ
What are BridgeBio Pharma's total assets?
BridgeBio Pharma reported total assets of $936.0 million at the end of fiscal 2025 (December 31, 2025), compared with $919.3 million a year earlier.
How much debt does BridgeBio Pharma have?
BridgeBio Pharma had $2.7 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does BridgeBio Pharma have?
BridgeBio Pharma held $587.5 million in cash and short-term investments at the end of fiscal 2025; with $2.7 billion of debt that is net debt of $2.1 billion.
What is BridgeBio Pharma's book value?
BridgeBio Pharma's shareholders' equity (book value) was -$2.1 billion at the end of fiscal 2025, or −$10.53 per share.
What is BridgeBio Pharma's current ratio?
BridgeBio Pharma had current assets of $753.7 million and current liabilities of $288.0 million, a current ratio of 2.62 (it can cover its short-term obligations).
How much goodwill does BridgeBio Pharma have?
BridgeBio Pharma carried $28.1 million of goodwill and intangible assets, 3.0% of total assets, at the end of fiscal 2025.